Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 6, 2013, Pages 3604-3615

  Zhang, Yu Sheng ^a   Xie, Ji Zhen ^b   Zhong, Julia Li ^c   Li, Yuan Yuan ^a   Wang, Rui Qi ^a   Qin, Yi Zhuo ^a   Lou, Hong Xiang ^a   Gao, Zu Hua ^d   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b Center for Drug Evaluation and Certification of Shandong   (China)

^c CHONGQING UNIVERSITY   (China)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Acetyl 11 keto boswellic acid (AKBA); Apoptosis; Gastric carcinoma; Inhibitory effect; Wnt catenin

Indexed keywords

ACETYL 11 OXO BETA BOSWELLIC ACID; ANTINEOPLASTIC AGENT; BETA CATENIN; CASPASE 3; CASPASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 1; ETOPOSIDE; GELATINASE A; MATRILYSIN; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SURVIVIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TREATMENT DURATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BCL-2-ASSOCIATED X PROTEIN; BETA CATENIN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS; TRITERPENES; TUMOR SUPPRESSOR PROTEIN P53; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; BOSWELLIA SERRATA; MUS; MUS MUSCULUS;

EID: 84876008661     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.03.003     Document Type: Article

References (44)

1. J. Wee, W.L. Nei, K.W. Yeoh, R.M. Yeo, S.L. Loong, and C.N. Qian Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK/T-cell lymphomas)? Med. Hypotheses 79 2012 833 842
2. L. Qiao, and B.C. Wong Targeting apoptosis as an approach for gastrointestinal cancer therapy Drug Resist. Updat. 12 2009 55 64
3. T. Chiba, H. Marusawa, and T. Ushijima Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation Gastroenterology 143 2012 550 563
4. H.P. Liu, Z.H. Gao, S.X. Cui, Y. Wang, B.Y. Li, H.X. Lou, and X.J. Qu Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta- boswellic acid in APC(Min/+) mice Int. J. Cancer 2012 10.1002/ijc.27929
5. B. Park, S. Prasad, V. Yadav, B. Sung, and B.B. Aggarwal Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets PLoS One 6 2011 e26943
6. V.R. Yadav, S. Prasad, B. Sung, J.G. Gelovani, S. Guha, S. Krishnan, and B.B. Aggarwal Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers Int. J. Cancer 130 2012 2176 2184
7. V.R. Sinha, A. Singh, S. Singh, and J.R. Bhinge Compression coated systems for colonic delivery of 5-fluorouracil J. Pharm. Pharmacol. 59 2007 359 365
8. H.Q. Yuan, F. Kong, X.L. Wang, C.Y. Young, X.Y. Hu, and H.X. Lou Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells Biochem. Pharmacol. 75 2008 2112 2121
9. K.S. Bauer, S.C. Dixon, and W.D. Figg Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent Biochem. Pharmacol. 55 1998 1827 1834
10. A. Baradaran-Heravi, A. Raams, J. Lubieniecka, K.S. Cho, K.A. DeHaai, M. Basiratnia, P.O. Mari, Y. Xue, M. Rauth, A.H. Olney, M. Shago, K. Choi, R.A. Weksberg, M.J. Nowaczyk, W. Wang, N.G. Jaspers, and C.F. Boerkoel SMARCAL1 deficiency predisposes to non-Hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo Am. J. Med. Genet. A 158A 2012 2204 2213
11. B. Yue, Y.S. Zhang, H.M. Xu, C.R. Zhao, Y.Y. Li, Y.Z. Qin, R.Q. Wang, D. Sun, Y. Yuan, H.X. Lou, and X.J. Qu Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way Cancer Lett. 328 2013 104 113
12. X. Xue, D.F. Sun, C.C. Sun, H.P. Liu, B. Yue, C.R. Zhao, H.X. Lou, and X.J. Qu Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies Lung Cancer 76 2012 300 308
13. C. Zhao, B. Yue, H. Liu, C. Sun, W. Li, and X. Qu SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine Toxicol. Appl. Pharmacol. 262 2012 293 300
14. Y.T. An, Z. Zhao, Y.C. Sheng, Y. Min, and Y.Y. Xia Therapeutic time window of YGY-E neuroprotection of cerebral ischemic injury in rats Drug Discov. Ther. 5 2011 76 83
15. P.J. Van Veldhuizen, G. Ray, S. Banerjee, G. Dhar, S. Kambhampati, A. Dhar, and S.K. Banerjee 2-Methoxyestradiol modulates beta-catenin in prostate cancer cells: a possible mediator of 2-methoxyestradiol-induced inhibition of cell growth Int. J. Cancer 122 2008 567 571
16. G.N. Wogan, S.S. Hecht, J.S. Felton, A.H. Conney, and L.A. Loeb Environmental and chemical carcinogenesis Semin. Cancer Biol. 14 2004 473 486
17. Q. Li, J. Zhang, Y.N. Zhou, and L. Qiao Obesity and gastric cancer Front. Biosci. 17 2012 2383 2390
18. B.G. Jang, and W.H. Kim Molecular pathology of gastric carcinoma Pathobiology 78 2011 302 310
19. L. Shao, H. Takeda, T. Fukui, K. Mabe, J. Han, S. Kawata, K. Ootani, and A. Fukao Genetic diversity of the Helicobacter pylori sialic acid-binding adhesin (sabA) gene Biosci. Trends 4 2010 249 253
20. S.C. Abraham, S.J. Park, J.H. Lee, L. Mugartegui, and T.T. Wu Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes Mod. Pathol. 16 2003 786 795
21. Y.S. Li, L.P. Wu, K.H. Li, Y.P. Liu, R. Xiang, S.B. Zhang, L.Y. Zhu, and L.Y. Zhang Involvement of nuclear factor κB (NF-κB) in the downregulation of cyclooxygenase-2 (COX-2) by genistein in gastric cancer cells J. Int. Med. Res. 39 2011 2141 2150
22. T. Sugai, M. Tsukahara, M. Endoh, Y. Shioi, N. Takebe, Y. Mue, H. Matsushita, M. Toyota, and K. Suzuki Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype BMC Gastroenterol. 10 2010 55
23. K.H. Lee, and J.R. Kim Regulation of HGF-mediated cell proliferation and invasion through NF-κB, JunB, and MMP-9 cascades in stomach cancer cells Clin. Exp. Metastasis 29 2012 263 272
24. Y. Takada, H. Ichikawa, V. Badmaev, and B.B. Aggarwal Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression J. Immunol. 176 2006 3127 3140
25. K. Sengupta, J.N. Kolla, A.V. Krishnaraju, N. Yalamanchili, C.V. Rao, T. Golakoti, S. Raychaudhuri, and S.P. Raychaudhuri Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract Mol. Cell. Biochem. 354 2011 189 197
26. Y. Zhang, and R.D. Duan Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells Lipids Health Dis. 8 2009 51
27. V. Devgan, C. Mammucari, S.E. Millar, C. Brisken, and G.P. Dotto p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation Genes Dev. 19 2005 1485 1495
28. L. Zhao, C. Zhang, G. Liao, and J. Long RNAi-mediated inhibition of PDGF-D leads to decreased cell growth, invasion and angiogenesis in the SGC-7901 gastric cancer xenograft model Cancer Biol. Ther. 9 2010 42 48
29. H.C. Zheng, X.Y. Xu, P. Xia, M. Yu, H. Takahashi, and Y. Takano Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas Hum. Pathol. 41 2010 1255 1264
30. C. Cai, and X. Zhu The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer Mol. Med. Rep. 5 2012 1191 1196
31. F. Nuñez, S. Bravo, F. Cruzat, M. Montecino, and G.V. De Ferrari Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells PLoS One 6 2011 e18562
32. S.J. Kühl, and M. Kühl On the role of Wnt/β-catenin signaling in stem cells Biochim. Biophys. Acta 1830 2012 2297 2306
33. P. Fishman, S. Bar-Yehuda, G. Ohana, F. Barer, A. Ochaion, A. Erlanger, and L. Madi An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B Oncogene 23 2004 2465 2471
34. W.C. Hawkes, and Z. Alkan Delayed cell cycle progression from SEPW1 depletion is p53- and p21-dependent in MCF-7 breast cancer cells Biochem. Biophys. Res. Commun. 413 2011 36 40
35. W. Yang, A. Velcich, I. Lozonschi, J. Liang, C. Nicholas, M. Zhuang, L. Bancroft, and L.H. Augenlicht Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2 -/- mice Am. J. Pathol. 166 2005 1239 1246
36. F. Takahashi-Yanaga, and T. Sasaguri Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs J. Pharmacol. Sci. 109 2009 179 183
37. N. Zhang, J. Zhang, L. Shuai, L. Zha, M. He, Z. Huang, and Z. Wang Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer Int. J. Oncol. 40 2012 2038 2048
38. F.T. Kolligs, G. Bommer, and B. Göke Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis Digestion 66 2002 131 144
39. W. He, R.J. Tan, Y. Li, D. Wang, J. Nie, F.F. Hou, and Y. Liu Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD J. Am. Soc. Nephrol. 23 2012 294 304
40. K.H. Lee, E.Y. Choi, M.S. Hyun, B.I. Jang, T.N. Kim, S.W. Kim, S.K. Song, J.H. Kim, and J.R. Kim Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells Eur. Surg. Res. 39 2007 208 215
41. S. Singh, A. Khajuria, S.C. Taneja, R.K. Khajuria, J. Singh, R.K. Johri, and G.N. Qazi The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats Phytomedicine 15 2008 408 415
42. M. Abdel-Tawab, O. Werz, and M. Schubert-Zsilavecz Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data Clin. Pharmacokinet. 50 2011 349 369
43. S. Sharma, V. Thawani, L. Hingorani, M. Shrivastava, V.R. Bhate, and R. Khiyani Pharmacokinetic study of 11-Keto beta-Boswellic acid Phytomedicine 11 2004 255 260
44. G.P. Stathopoulos, D. Trafalis, J. Dimitroulis, C. Kosmas, J. Stathopoulos, and D. Tsavdaridis Combination of three cytotoxic agents in small-cell lung cancer Cancer Chemother. Pharmacol. 72 2012 413 418